Current Cancer Drug Targets
Title: EDITORIAL [Hot topic: New Therapeutic Advances and Perspectives in Tumour Angiogenesis (Guest Editor: Eddy Pasquier)]
Volume: 10 Issue: 8
Author(s): Eddy Pasquier and Nicolas Andre
Affiliation:
Export Options
About this article
Cite this article as:
Pasquier Eddy and Andre Nicolas, EDITORIAL [Hot topic: New Therapeutic Advances and Perspectives in Tumour Angiogenesis (Guest Editor: Eddy Pasquier)], Current Cancer Drug Targets 2010; 10 (8) . https://dx.doi.org/10.2174/156800910793358032
DOI https://dx.doi.org/10.2174/156800910793358032 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
18
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Obesity Modulation - The Role in Carcinogenesis
Anti-Cancer Agents in Medicinal Chemistry Current and Future Drugs for Appetite Regulation and Obesity Treatment
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Role of microRNAs in Cardiovascular Disease
Current Medicinal Chemistry Inhibitory Effect of Fruit Juices on the Doxorubicin Metabolizing Activity of Carbonyl Reductase 1
Drug Metabolism Letters Toll-Like Receptors and Human Disease: Lessons from Single Nucleotide Polymorphisms
Current Genomics Anesthesia Issues in Central Nervous System Disorders
Current Aging Science Role of Endogenous Androgen Against Insulin Resistance and Athero-sclerosis in Men with Type 2 Diabetes
Current Diabetes Reviews Linkage of Stress with Neuromuscular Disorders
CNS & Neurological Disorders - Drug Targets Role of NUCB2/nesfatin-1 as a Possible Biomarker
Current Pharmaceutical Design Psychosocial Risk Factors Related to Ischemic Heart Disease in Women
Current Pharmaceutical Design Novel and Emerging Drugs for Rarer Chronic Lymphoid Leukaemias
Current Cancer Drug Targets Stable Angina Pectoris: Current Medical Treatment
Current Pharmaceutical Design Immunoregulatory Impact of Food Antioxidants
Current Pharmaceutical Design Hemolytic Uremic Syndrome in Children
Current Pediatric Reviews Serum Interleukin-33 as a Biomarker in Predicting Neonatal Sepsis in Premature Infants
Combinatorial Chemistry & High Throughput Screening Hepatoblastoma: Review of Pathology, Diagnosis and Modern Treatment Strategies
Current Cancer Therapy Reviews Vitamin D and the Metabolic Syndrome
Current Vascular Pharmacology Towards a “Metabolic” Subtype of Major Depressive Disorder: Shared Pathophysiological Mechanisms May Contribute to Cognitive Dysfunction
CNS & Neurological Disorders - Drug Targets Reproductive Toxicology of Environmental Toxicants: Emerging Issues and Concerns
Current Pharmaceutical Design CD164 as a Basophil Activation Marker
Current Pharmaceutical Design